
Antibody, not a vaccine
CIMAher (nimotuzumab)
An antibody medicine that targets the EGFR receptor on tumour cells.
- Who it is for
- Locally advanced or metastatic adenocarcinoma of the pancreas, together with chemotherapy.
- How it is given
- Into a vein, as a drip. The doctor sets the dose and how often it is given.
- Licence
- Licensed in Cuba since 2002 (CECMED); not approved in the US or the European Union.







